Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

Cited by (999)

Items 901–999 of 999

1. Stem cells and neurodegenerative disorders
   Mark P. Mattson, Norman J. Haughey, Aiwu Cheng, Mahendra S. Rao · 2002 · Advances in cell aging and gerontology
2. Perturbed calcium homeostasis in neurodegenerative disorders
   Mark P. Mattson · 2001 · Advances in cell aging and gerontology
3. Neuronal apoptosis and the pathogenesis of Alzheimer's and Parkinson's diseases
   Mark P. Mattson, Qing Guo, Wenzhuan Duan, Sic L. Chan · 2001 · Advances in cell aging and gerontology
4. Developmental Mechanisms in Aging and Age-Related Diseases of the Nervous System
   Mark P. Mattson, Tobi L. Limke · 2006 · Kluwer Academic Publishers-Plenum Publishers eBooks
5. PROTECTIVE EFFECTS OF Α - CRYSTALLIN ON Β - AMYLOID (Aβ) INDUCED TOXICITY
   K. Gomathi Gopinathan, Dasararaju Gayathri · 2015 · International Journal of Pharmacy and Pharmaceutical Sciences
6. Neurodegeneration induced by clostridial neurotoxins in cerebellar granule neurons: a novel in vitro model for neurodegenerative disease
   Laura Berliocchi · 2000 · KOPS (University of Konstanz)
7. Chapter 7 Cerebrovascular Disease
   LaRoy P. Penix, Douglas John Lanska · 1999 · Advances in cell aging and gerontology
8. Estudo das atividades de reparo de DNA por excisão de bases em extratos mitocondriais de cérebros de indivíduos normais e acometidos pela doença de Alzheimer
   Carolina Parga Martins Pereira · 2014
9. Construction of Affinity Probes to Study the Epothilone Binding Site on Tubulin
   Emily A. Reiff, Gunda I. Georg · 2003
10. Processing of the amyloid precursor protein and its paralogues amyloid precursor-like proteins 1 and 2
    Linda Adlerz · 2007 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
11. Regenerating the brain: Stem cell differentiation and cholinergic dysfunction in Alzheimer disease
    Linn Malmsten · 2014 · Figshare
12. Gene regulation as a potential avenue for the treatment of neurodegenerative disorders
    David R. Brown · 2009 · Expert Opinion on Drug Discovery
13. Delineation of the functional domains of the extracellular region of YWK-II Protein/APLP2 of sperm membrane
    Dazhong Zhuang · 2006 · Frontiers in bioscience
14. The endocytic protein numb regulates APP metabolism and Notch signaling: Implications for Alzheimer's disease
    George A. Kyriazis · 2008 · Journal of International Crisis and Risk Communication Research
15. Infrared spectroscopic studies : from small molecules to large
    Nadejda Eremina · 2014 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
16. The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: III Pharmacological Studies
    Peter K. Panegyres, Emily Atkins · 2011 · Neuroscience &amp Medicine
17. The evolution of aging-related brain change
    Jeff Victoroff · 1999 · Neurobiology of Aging
18. Frontiers in Research Reviews: Adult Neurogenesis in the Healthy and Dysfunctional Brain REGULATORS OF ADULT NEUROGENESIS IN THE HEALTHY AND DISEASED BRAIN
    Helen Grote, Anthony John Hannan · 2007
19. The influence of amyloid-beta, a major pathological marker in Alzheimer's disease, on molecular cognitive processes of APP+PS1 transgenic mice
    Chad A. Dickey · 2004 · Digital Commons - University of South Florida (University of South Florida)
20. Amyloid Beta Precursor Protein: Proper Credit for the Basic Biochemical Properties of the Most Studied Protein in the 21st Century*
    Rafael Franco, Gemma Navarro, Martínez Pinilla E · 2014 · Journal of Neurology and Neurological Disorders
21. Effects of amyloidogenic peptides on the phosphorylation state of the tau-protein and on the expression of the alpha7 subunit of the nicotinic acetylcholine receptor in vitro
    Enzo Lain · 2004 · Kölner Universitäts PublikationsServer (Universität zu Köln)
22. Production et catabolisme des peptides amyloïdes dans la maladie d’Alzheimer
    Frédéric Checler · 2010 · Therapies
23. Overexpression of APPL, a Drosophila APP Homologue, Compromises Microtubule Associated Axonal Transport and Promotes Synapse Formation
    Laura Torroja, Mary C. Packard, Vivian Budnik, K. White · 2001 · Research and perspectives in Alzheimer's disease
24. PLASTICITY IN THE ENTORHINAL-HIPPOCAMPAL
    Inga Kadish · 2002
25. Métabolisme du peptide
    Cécile Dumanchin‐Njock, Elvira Lopez‐Perez, Philippe Marambaud, Erwan Paitel, Agnès Petit-Paitel, Bruno Vincent · 2002
26. L-3-n-ButylphthalideImprovesCognitiveImpairmentand ReducesAmyloid-inaTransgenicModelofAlzheimer's Disease
    AlyssaN . Nylander · 2010
27. Proponiendo biomarcadores para evaluar las alteraciones en la homeostasis cerebral de hierro y su relación con la fisiopatología de la Enfermedad de Alzheimer Proposing biomarkers to evaluate the alterations in the brain iron homeostasis and their relation with the physiopathology of Alzheimer's disease
    Alexis Tapia S · 2007
28. UNIVERSITA' DEGLI STUDI DI NAPOLI FEDERICO II Ph.D. in Molecular Medicine - Ciclo VIII/XXVI Human Genetics
    Sede Di Napoli · 2009
29. Plant-based vaccines for Alzheimer's disease: an
    O Dania, Leticia Moreno‐Fierros · 2014
30. Genetic and Expressional Studies of Alzheimer's Disease
    Susan Iivonen · 2005
31. Investigação do efeito neuroprotetor da atorvastatina em um modelo in vitro de toxicidade induzida pelo peptídeo β-amiloide
    Thaline da Silva · 2012 · Americanae (AECID Library)
32. Alterations in Raft Lipid Metabolism in Aging and Neurodegenerative Disorders
    Mark P. Mattson, Roy G. Cutler, Norman J. Haughey · 2005 · Humana Press eBooks
33. Effects of [beta]-amyloid on glucose uptake by cultured hippocampal neurons
    Teerasak Prapong · 1998
34. Adaptive responses of central cholinergic systems in transgenic mice
    Joachim Hartmann · 2006 · ThinkTech (Texas Tech University)
35. REDOX PROCESSES AND OXIDATIVE STRESS IN CELL AND TISSUE DAMAGE
    Lisa Arodin Selenius · 2015 · Figshare
36. Proteomic Analysis Identifies Translationally Controlled Tumor Protein as a Potential Novel Mediator of Occlusive Vascular Remodeling in Pulmonary Arterial Hypertension
    Jessie R. Lavoie · 2013 · uO Research (University of Ottawa)
37. Interactions of amyloid precursor protein (APP) and its biological significance
    Yingjiu Zhang · 2009 · Shengming kexue
38. P2‐053: Olfactory deprivation hastens Alzheimer‐like pathologies in a human tau overexpressed mouse model via activation of cdk5
    Ke Li, Fangfang Liu, Jian‐Zhi Wang, Ling‐Qiang Zhu · 2015 · Alzheimer s & Dementia
39. Intracellular Accumulation of Amyloid β and Mitochondrial Dysfunction in Down’s Syndrome
    Jorge A. Busciglio, Pablo R. Helguera, Atul M. Deshpande, Alejandra Pelsman · 2004 · CRC Press eBooks
40. Oxidative Stress and AbetaPP Processing
    Elena Tamagno, Massimo Tabaton · 2005 · Oxidative stress and disease
41. Genetic Models of Alzheimer’s Disease: The Influence of Apolipoprotein E allele Isoforms on Behaviour in Laboratory Animals
    Matthew A. Albrecht, Jonathan K. Foster · 2016 · Springer eBooks
42. Strategies for Crystallizing the N-Terminal Growth Factor Domain of Amyloid Precursor Protein
    Roberto Cappai, Denise Galatis, Susanne C. Feil · 2004 · CRC Press eBooks
43. Oxidative Stress in Down Syndrome: A Paradigm for the Pathogenesis of Neurodegenerative Disorders
    Rocco C. Iannello, Ismail Kola · 2003 · Humana Press eBooks
44. Quantitative analysis of neuropathological alterations in two transgenic mouse models of Alzheimer's disease
    Anastasiia Kurdakova · 2016
45. The Search for Biomarkers in Alzheimer's Disease
    Anna Meiliana, Andi Wijaya · 2010 · The Indonesian Biomedical Journal
46. Tolfenamic Acid Interrupts the De Novo Synthesis of Plaque-Forming Amyloid Beta Peptides: Implications for Alzheimers Disease
    Lina I. Adwan · 2008
47. Histological Evidence Of The Effect Of Oil Palm Phenolics In Atherogenic Diet Induced Rat Model Of Alzheimer’s Disease
    Kenechukwu Monplaisir Monplaisir · 2016 · Human Biology
48. In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
    Bernhard Clemens Richard · 2015
49. Aging of cerebellar granule neurons in vitro
    Ana Pekanovic · 2006
50. Charakterisierung von Prädiktoren rapid-progressiver Verläufe des M. Alzheimer
    Thomas Bartlau · 2016
51. Remodelado del calcio intracelular y susceptibilidad a la muerte neuronal en el envejecimiento y en la enfermedad de Alzheimer
    María Calvo Rodríguez · 2015
52. Envolvimento da NADPH oxidase 2 na neurodegeneração induzida por estreptozotocina.
    Katherine Garcia Ravelli · 2018
53. Analyse neurodegenerativer Prozesse im Gyrus Dentatus im Tg4-42-Mausmodell der Alzheimerdemenz
    Nils L. Schubert · 2018
54. Antihypertension drugs in prevention of cognition disorder and dementia: focus on calcium channel blockers and diuretics
    Ol'ga Dmitrievna Ostroumova, Черняева Марина Сергеевна · 2018 · CARDIOVASCULAR THERAPY AND PREVENTION
55. Avaliação de mecanismos de prevenção e tratamento com microdose de lítio e associação com rivastigmina em modelo de neurodegeneração por infusão crônica de >font face = \"symbol\"/font<-amiloide.
    Natália Mendes Schöwe · 2019 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
56. The role of APP and its homologous proteins in synaptic function and plasticity
    Bettina Susanne Kilian · 2008 · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG))
57. Oxidative modification of vesicular transporters in an animal model of Alzheimer’s disease
    Ying Wang · 2015 · Mspace (University of Manitoba)
58. Deep Skills: Positive Mind Neuroscience of Exercise To Counter Covid 19
    Dario Furnari · 2020 · Journal of Oncology Research Review & Reports
59. Cerebrovascular Dysfunction and Degeneration in Alzheimer’s Disease Pathophysiology
    Dominic Dimitri Quintana · 2020
60. Técnicas computacionais aplicadas a uma série de antagonistas do receptor 5-HT>sub<6>/sub< - potencial alvo para a doença de Alzheimer
    Aldineia Pereira da Silva · 2021
61. Search for early TTR-related biomarkers in a transgenic AD mouse model
    Luís Miguel Santos · 2013 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
62. Protease Nexins
    Solange Moll, Shozo Izui · 2002 · Wiley Encyclopedia of Molecular Medicine
63. Does a rare mutation in PTPRA contribute to the development of Parkinson’s disease in an Australian multi-incident family?
    Melissa A. Hill, Steven R. Bentley, Tara L. Walker · 2022 · PLoS ONE
64. Passive Immunisierung mit dem monoklonalen Antikörper NT4X am Tg4-42-Mausmodell für die sporadische Form der Alzheimer Erkrankung
    Philipp Henniges · 2023
65. Eucommiae cortex polysaccharides ameliorates learning and memory deficits in Alzheimer's disease mice by modulating gut microbiota and glutamate metabolism
    Yongkang Zhao, Wenxing Zhao, Xuejun Chai, Lulu Zhang, Junlang Huang, Penghao Sun, Xingrui Guo, Chenju Yi, Xiaoyan Zhu, Shanting Zhao · 2023 · Research Square
66. Restoring Neuronal Excitability and Spatial Memory Through Inhibiting Amyloid-Β-Induced Hyperactive Nf-Κb in a Rat Model of Alzheimer's Disease
    Mohammad Javad Eslamizade, Zahra Soleimani, Shima Davoudi, Fatemeh Saffarzadeh, Zeinab Parvin, Mehdi Mehdizadeh, Mona Rahdar, Narges Hosseinmardi, Mahyar Janahmadi · 2025 · SSRN Electronic Journal
67. Immunosuppressants and Alzheimer’s Disease
    Mark P. Mattson · 2003 · Humana Press eBooks
68. Aß Toxicity in Alzheimer’s Disease
    William L. Klein · 2001 · Humana Press eBooks
69. Activity-regulated retinoic acid signaling in olfactory sensory neurons
    Hande Login · 2014 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
70. REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR SPLICING EFFICIENCY
    I‐Fang Ling · 2009 · UKnowledge (University of Kentucky)
71. Cysteine Proteases, Synaptic Degeneration and Neuroodegenerative Disorders
    Mark P. Mattson, Sic L. Chan · 2002 · Springer eBooks
72. A study of the role of presenilin (1) in regulating synaptic function at hippocampal synapses
    Lily M. Y. Yu · 2010 · UCL Discovery (University College London)
73. Chapter 6 Calcium and the pathogenesis of neurodegenerative disorders
    Mark P. Mattson, Charles Gilman · 2002 · Advances in cell aging and gerontology
74. Modulation of apolipoprotein E receptor-2 by ApoE4, amyloid β-peptide, reelin, and secreted amyloid precursor protein: a common point of impact in Alzheimer’s disease pathogenesis
    Steven W. Barger, A. Moerman · 2026 · Frontiers in Molecular Neuroscience
75. Transcytose à travers la barrière hémato-encéphalique : étude in vitro du transport des lipoproteines de basse densité et du peptide ß-amyloïde
    Pietra Candela · 2010 · theses.fr (ABES)
76. Implication du complexe récepteur 5-HT4/APP/ADAM10 dans la voie non-amyloïdogénique de la maladie d’Alzheimer
    Maud Cochet · 2011 · theses.fr (ABES)
77. Etude du complexe récepteur 5-HT4/ADAM10/APP et recherche de protéines associées à l’ADAM10 : de nouveaux acteurs favorisant la voie non-amyloïdogénique dans le contexte de la maladie d'Alzheimer
    Romain Donneger · 2014 · theses.fr (ABES)
78. Implication de l'acide docosanoïque (C22 0) et des acides gras à très longue chaîne (acide tétracosanoïque (C24 0), acide hexacosanoïque ( C26 0) dans la maladie d'Alzheimer : aspects biologiques et cliniques
    Amira Zarrouk · 2013
79. Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer
    Valentine Hamm · 2016 · theses.fr (ABES)
80. Mitochondria, neurosteroids and biological rhythms : implications in health and disease states
    Amandine Grimm · 2015 · theses.fr (ABES)
81. The role of the nicotinic receptors in prefrontal cortex spontaneous neuronal activity in the normal and diseased brain
    Fani Koukouli · 2016 · theses.fr (ABES)
82. Impact de l'hypertension artérielle et sa prise en charge par les médicaments antihypertenseurs sur les troubles cognitifs et la démence
    Laure Rouch · 2016
83. Faisabilité et comparaison d'un entrainement aérobie de type continu ou intermittent sur les capacités physiologiques, cognitives et la qualité de vie, chez des personnes âgées présentant un trouble neurocognitif majeur associé à la maladie d'Alzheimer
    Lievyn Enette · 2019 · theses.fr (ABES)
84. Effects of zinc and copper ions in the amyloid cascade linked to Alzheimer's disease
    Valentina Borghesani · 2018 · theses.fr (ABES)
85. De la fonction physiologique de la protéine prion cellulaire aux maladies neurodégénératives amyloïdes
    Hélène Arnould · 2019 · theses.fr (ABES)
86. La protéine prion cellulaire : rôles physiologiques et implications croisées dans les maladies neurodégénératives amyloïdes
    Vincent Baudouin · 2020 · theses.fr (ABES)
87. 3S-HS et HS3ST2 dans les macrophages humains : implication dans le diagnostic de la maladie d'Alzheimer
    Oulfa Ben Abdelouahab · 2021 · theses.fr (ABES)
88. Maladies neurodégénératives et stress oxydant
    Elise Lévy · 2020 · theses.fr (ABES)
89. Différences mâles/femelles dans les effets de l'éthanol sur la plasticité hippocampique chez le rat adolescent : rôle des œstrogènes
    Kevin Rabiant · 2020 · theses.fr (ABES)
90. Early memory deficits and extensive brain network disorganization in the AppNL-F/MAPT double knock-in mouse model of familial Alzheimer's disease
    Christopher Borcuk · 2021 · theses.fr (ABES)
91. Implication de la protéine prion cellulaire dans la neurotoxicité de protéines amyloïdes et de nanoparticules
    Luiz W. Ribeiro · 2023 · theses.fr (ABES)
92. Contribution à l'étude des facteurs de risque pour la maladie d'Alzheimer : analyse de candidats identifiés par étude d'association pangénomique ou GWAS
    Charlotte Bauer · 2023 · theses.fr (ABES)
93. Myelin alterations in early stages of Alzheimer's disease and preclinical assessment of the protective and therapeutic potential of neurosteroid 3α-O-allyl-allopregnanolone
    Nwife Getrude Okechukwu · 2023 · theses.fr (ABES)
94. The light at the end of the tunnel : study of early-stage brain dynamics alterations in Alzheimer’s disease and beneficial effects of light stimulation in the AppNL-F/MAPT mouse model
    Matthieu Aguilera · 2024 · theses.fr (ABES)
95. Molekulargenetik und Molekularbiologie der Alzheimer-Krankheit
    Rupert Sandbrink, Konrad T. Beyreuther · 1999 · Springer eBooks
96. Potential biomarkers for Alzheimer's disease and mild cognitive impairment
    Meghan B. Mitchell · 2009
97. Papel do receptor B2 para as cininas na neuroinflamação induzida pelo peptídeo beta-amilóide
    Maira Assunção Bicca · 2012 · Americanae (AECID Library)
98. Untitled work
    MP Mattson · 1999 · 10.1002/(sici)1097-4547(19991001)58:1
99. Impairment of hippocampal long-term potentiation by Alzheimer amyloid ?-peptides
    Chen, Qi-Sheng, Kagan, Bruce L., Hirakura, Yutaka, Xie, Cui-Wei · 2000 · Journal of Neuroscience Research